Breviscapine alleviates MPP+-induced damage and apoptosis of SH-SY5Y cells by activating Nrf2 pathway

Dongzhu Li(First People's Hospital of Jingzhou), Tao Tan(Anhui Medical University)
Tropical Journal of Pharmaceutical Research
May 28, 2022
10.4314/tjpr.v21i3.2
Cited by 0

Related Papers

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Cancer Discovery|2023|91
Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids
|STAR Protocols|2024|11
Supplementary Data Table S6 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Unknown|2024|0
Supplementary Data Figure S1 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Unknown|2024|0
Supplementary Data Figure S27 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Unknown|2024|0